Whinnett, Zachary ISohaib, S M AfzalJones, SianaKyriacou, AndreasMarch, KatherineCoady, EmmaMayet, JamilHughes, Alun DFrenneaux, MichaelFrancis, Darrel PBRAVO Investigators2014-12-182014-12-182014-04-03Whinnett, Z I, Sohaib, S M A, Jones, S, Kyriacou, A, March, K, Coady, E, Mayet, J, Hughes, A D, Frenneaux, M, Francis, D P & BRAVO Investigators 2014, 'British randomised controlled trial of AV and VV optimization ("BRAVO") study : rationale, design, and endpoints', BMC Cardiovascular Disorders, vol. 14, 42. https://doi.org/10.1186/1471-2261-14-42http://hdl.handle.net/2164/4113956871engBiological MarkersBlood Pressure DeterminationCardiac Resynchronization TherapyCardiac Resynchronization Therapy DevicesClinical ProtocolsCross-Over StudiesEchocardiography, DopplerExercise TestExercise ToleranceGreat BritainHeart FailureHemodynamicsHumansNatriuretic Peptide, BrainPeptide FragmentsPhotoplethysmographyPredictive Value of TestsQuality of LifeQuestionnairesRecovery of FunctionResearch DesignTime FactorsTreatment OutcomeVentricular Function, LeftVentricular RemodelingOptimizationR MedicineRBritish randomised controlled trial of AV and VV optimization ("BRAVO") study : rationale, design, and endpointsJournal article10.1186/1471-2261-14-4214